Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement
Merck's Luther Clark discusses how the organization is partnering with patients and community organizations, engaging with frontline providers, and addressing the hurdles of participation, all to provide more patients with greater access to trials.

In this session from the March 2025 Patients as Partners in Clinical Research conference, Merck presented how they advanced patient and community engagement through targeted initiatives designed to improve trial participation, relevance, and long-term impact. The key topics addressed included:
- Identifying and addressing patient and community needs
- Strategies for earning trust and fostering sustained engagement
- Key collaborations and partnerships driving meaningful change
- Approaches to developing patient-centered endpoints and outcomes
- Methods for effectively communicating and disseminating trial results
For more information, go to PatientsAsPartnersconference.com.
Related Podcasts
View All
Ensuring Continuity in Patient Insights to Strengthen Medicine Development

Catalyzing Change: The Business Imperative of Patient-Centric Drug Development

The Life-Changing Power of a Clinical Trial, from a Caregiver's Perspective

Streamlining Effective Patient Engagement through Pharma-Patient Advocacy Collaboration
Sponsored